HopeStage
Back to all studies
CompletedNCT02914769

Ayahuasca for Treatment-Resistant Depression: A Placebo-Controlled Study

About this titleRead the official source — NCT02914769
Medication studyAges 18–60Brazil
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2014
Recruitment status
Completed
Enrollment listed in the registry
35
Sponsor
Universidade Federal do Rio Grande do Norte
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Brazil
Age range
From 18 Years to 60 Years
Official registry ID
NCT02914769
Official title
Show the full official title

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Natal

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universidade Federal do Rio Grande do Norte.

Did this study involve medication?

Yes. The study involved medication, including Ayahuasca and placebo.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies